In Brief: Ballard Medical
This article was originally published in The Gray Sheet
Executive Summary
Ballard Medical: Purchases 90% stake in Cardiotronics Systems, a Carlsbad, California-based developer of "disposable stimulation electrodes" for acute management of heart rate disorders. The electrodes are designed to replace defibrillator paddles and can be used with any manufacturer's defibrillator, Ballard says. The company paid $11.4 mil. ($3.75 per share) for its stake in the company...